SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject3/19/2003 8:32:15 AM
From: nigel bates   of 625
 
Cambridge Antibody Technology Acknowledges Anthrax Drug
Wednesday March 19, 6:42 am ET

LONDON -(Dow Jones)- Cambridge Antibody Technology said Wednesday that it acknowledges the announcement made by Human Genome Sciences, Inc. (NasdaqNM:HGSI - News) about its discovery and development of a human monoclonal antibody drug, ABthraxTM, that is effective in protecting against anthrax in multiple experimental models.

HGSI plans to file an Investigational New Drug application in the near future, seeking clearance from the U.S.' Food and Drug Administration to begin clinical trials in the U.S. to evaluate the safety, tolerability and pharmacology of ABthrax in healthy adults.

CAT confirmed that the ABthrax antibody was isolated and developed by HGSI from libraries it has licensed to HGSI.

"We are delighted with the success that HGSI is having in working with the libraries we licensed to them," said Peter Chambre, CAT's chief executive. " ABthrax is the fourth human monoclonal antibody to come from CAT's collaboration with HGSI and we continue to be pleased with the productivity of this relationship".

CAT has already received a licence fee for the antibody and is entitled to receive clinical development milestones and royalties on product sales from HGSI...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News